Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
KERX [NASD]
Keryx Biopharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.57 Insider Own1.40% Shs Outstand90.91M Perf Week1.21%
Market Cap1.29B Forward P/E28.86 EPS next Y0.49 Insider Trans-15.53% Shs Float88.85M Perf Month-4.11%
Income-46.70M PEG- EPS next Q-0.08 Inst Own62.10% Short Float19.16% Perf Quarter-7.48%
Sales7.00M P/S184.81 EPS this Y-65.70% Inst Trans2.95% Short Ratio5.44 Perf Half Y26.38%
Book/sh0.55 P/B25.87 EPS next Y198.00% ROA-59.80% Target Price25.64 Perf Year71.03%
Cash/sh0.61 P/C23.23 EPS next 5Y30.00% ROE-71.80% 52W Range6.61 - 17.46 Perf YTD9.88%
Dividend- P/FCF- EPS past 5Y13.20% ROI-103.70% 52W High-20.85% Beta3.99
Dividend %- Quick Ratio3.70 Sales past 5Y42.30% Gross Margin- 52W Low109.08% ATR0.89
Employees41 Current Ratio3.70 Sales Q/Q- Oper. Margin- RSI (14)37.05 Volatility5.87% 6.91%
OptionableYes Debt/Eq0.00 EPS Q/Q-133.30% Profit Margin- Rel Volume0.48 Prev Close14.23
ShortableYes LT Debt/Eq0.00 EarningsMay 05 Payout- Avg Volume3.13M Price13.82
Recom1.60 SMA20-9.88% SMA50-10.77% SMA20012.90% Volume1,307,717 Change-2.88%
04-Apr-14Reiterated Ladenburg Thalmann Buy $24 → $30
02-Apr-14Reiterated Mizuho Buy $25 → $34
01-Apr-14Reiterated Oppenheimer Outperform $20 → $22
21-Mar-14Initiated Mizuho Buy $25
14-Mar-14Reiterated Stifel Buy $17 → $19
27-Jan-14Reiterated Maxim Group Buy $16 → $25
17-Oct-13Reiterated Ladenburg Thalmann Buy $15 → $19
01-Aug-13Reiterated Maxim Group Buy $9 → $12
29-Jan-13Reiterated Stifel Nicolaus Buy $4 → $13
29-Jan-13Reiterated MLV & Co Buy $5 → $15
29-Jan-13Reiterated Ladenburg Thalmann Buy $5 → $15
29-Jan-13Reiterated Burrill Institutional Research Mkt Outperform $6 → $11
28-Jan-13Reiterated Maxim Group Buy $4 → $9
13-Dec-12Initiated Maxim Group Buy $4
13-Nov-12Initiated Burrill Institutional Research Mkt Outperform $6
10-Oct-12Reiterated Ladenburg Thalmann Buy $3 → $5
10-May-12Upgrade Ladenburg Thalmann Neutral → Buy $3
03-Apr-12Downgrade Ladenburg Thalmann Buy → Neutral
02-Apr-12Reiterated Brean Murray Buy $10 → $5
17-May-11Initiated Oppenheimer Outperform $7
16-Apr-14 10:45AM  Keryx Biopharmaceuticals: Is The High Valuation Justified? at Seeking Alpha
15-Apr-14 08:30AM  Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal GlobeNewswire
11-Apr-14 09:00AM  Reviewing An Aggressive Strategy In A Volatile Market at Forbes
09-Apr-14 08:30AM  Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at the Upcoming National Kidney Foundation 2 GlobeNewswire
03-Apr-14 05:20PM  Good News for Keryx Zacks
02-Apr-14 09:22AM  Keryx price target raised to $34 from $25 at Mizuho at theflyonthewall.com
08:30AM  Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM) GlobeNewswire
01-Apr-14 08:30AM  High-Risk Small Cap Biotech Keryx Pharma Has Become Overvalued at Seeking Alpha
31-Mar-14 03:10PM  Medicare Band-Aid Sends 1 Biotech Stock Surging at Motley Fool
29-Mar-14 08:15AM  3 Humongous Health-Care Stocks This Week at Motley Fool
27-Mar-14 11:52AM  Use Options For A Chance To Buy KERX At A 39% Discount at TheStreet
02:39AM  Keryx Biopharmaceuticals Inc. (KERX) Worth Watching: Stock Surges 17.4% Zacks
26-Mar-14 07:17PM  Keryx CEO Says U.S. House Bill Would Help on Drug Pricing at Bloomberg +17.39%
05:15PM  Why Keryx Biopharmaceuticals, Yongye International, and Five Below Are Today's 3 Best Stocks at Motley Fool
21-Mar-14 06:31AM  Coverage initiated on Keryx Biopharma by Mizuho Briefing.com
19-Mar-14 01:04PM  KERYX BIOPHARMACEUTICALS INC Financials EDGAR Online Financials
17-Mar-14 08:30AM  Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo GlobeNewswire
13-Mar-14 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
01:25PM  Keryx Biopharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
01:25PM  Keryx Biopharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript
12:20PM  Wider Q4 Loss at Keryx Zacks
12:20PM  Wider Q4 Loss at Keryx
08:30AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:19AM  Keryx Biopharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q4 2013 Keryx Biopharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
12-Mar-14 05:24PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events EDGAR Online
04:30PM  Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results GlobeNewswire
11-Mar-14 04:30PM  Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2013 Financial Results GlobeNewswire
10-Mar-14 08:50AM  Keryx announces submission of MAA for Zerenex to EMA at theflyonthewall.com
08:50AM  Keryx announces submission of MAA for Zerenex to EMA
08:30AM  Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency GlobeNewswire
26-Feb-14 03:27PM  Six stocks to watch at MarketWatch
08:30AM  Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences GlobeNewswire
25-Feb-14 02:15PM  [video] TG Therapeutics CEO: Stock Volatile But Cancer Drugs on Track at TheStreet
08:48AM  Ferric Citrate [Zerenex] For The Treatment Of Hyperphosphatemia: A New Use For An Old Compound at Seeking Alpha
18-Feb-14 08:30AM  Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing GlobeNewswire
10-Feb-14 05:04PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
08:34AM  Keryx appoints Appoints Greg Madison as COO theflyonthewall.com
08:30AM  Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer GlobeNewswire
06-Feb-14 08:30AM  Keryx Biopharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference GlobeNewswire
30-Jan-14 12:30PM  [video] Joe Theismann's investing playbook at CNBC
12:30PM  [video] Joe Theismann's investing playbook
05:57AM  Investors are betting against Keryx Biopharmaceuticals (KERX), Should You? Zacks
05:57AM  Investors are betting against Keryx Biopharmaceuticals (KERX), Should You?
05:53AM  Keryx Biopharmaceuticals (KERX) Shares March Higher, Can It Continue? Zacks
05:53AM  Keryx Biopharmaceuticals (KERX) Shares March Higher, Can It Continue?
28-Jan-14 09:01AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.10%
09:01AM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
24-Jan-14 11:45AM  Use Options For A Chance To Buy KERX At A 31% Discount at TheStreet
11:45AM  Use Options For A Chance To Buy KERX At A 31% Discount
22-Jan-14 07:42PM  Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire -5.07%
07:42PM  Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
02:54PM  Why Keryx Biopharmaceuticals, Inc. Shares Sank at Motley Fool
02:54PM  Why Keryx Biopharmaceuticals, Inc. Shares Sank
04:32AM  Keryx Biopharmaceuticals: Grim Realities Of The Dialysis Market Will Result In Commercial Failure at Seeking Alpha
04:32AM  Keryx Biopharmaceuticals: Grim Realities Of The Dialysis Market Will Result In Commercial Failure
21-Jan-14 04:20PM  Keryx files to sell $90M of common stock at theflyonthewall.com
04:20PM  Keryx files to sell $90M of common stock
04:19PM  Keryx Biopharmaceuticals, Inc. Announces $90 Million Proposed Public Offering of Common Stock PR Newswire
04:19PM  Keryx Biopharmaceuticals, Inc. Announces $90 Million Proposed Public Offering of Common Stock
08:30AM  Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access GlobeNewswire
08:30AM  Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
06:19AM  Keryx Biopharmaceuticals (KERX) in Focus: Stock Adds 6.8% in Session Zacks
06:19AM  Keryx Biopharmaceuticals (KERX) in Focus: Stock Adds 6.8% in Session
20-Jan-14 03:40PM  Positive News for Keryx Zacks
03:40PM  Positive News for Keryx
17-Jan-14 05:02PM  KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.88%
08:00AM  Keryx Biopharmaceuticals Announces Marketing Approval of Ferric Citrate in Japan PR Newswire
15-Jan-14 03:48PM  Keryx Biopharmaceuticals CEO Presents at JPMorgan Healthcare Conference (Transcript) at Seeking Alpha
10:12AM  J.P. Morgan Healthcare Confab Live Blog: Day Three at TheStreet
10:12AM  J.P. Morgan Healthcare Confab Live Blog: Day Three
13-Jan-14 09:06AM  Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends at Seeking Alpha -6.37%
09:06AM  Stock Watch Monday, 13 January 2014: Intercept Soars As Focus Shifts To Healthcare Market Trends
07-Jan-14 08:30AM  Keryx Biopharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference GlobeNewswire
08:30AM  Keryx Biopharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
31-Dec-13 12:06AM  Understanding Zerenex's Patent Protection And Latest Issuance at Seeking Alpha
12:06AM  Understanding Zerenex's Patent Protection And Latest Issuance
30-Dec-13 01:15PM  [video] Russell stocks up 400 percent in 2013 at CNBC
01:15PM  [video] Russell stocks up 400 percent in 2013
12:27PM  Taking A Look At A Few Of The Top Performers Of 2013 at Seeking Alpha
09:19AM  The Billion-Dollar Biotech Club: Speculation Trumped Risk at TheStreet
09:19AM  The Billion-Dollar Biotech Club: Speculation Trumped Risk
08:30AM  The Billion-Dollar Biotech Club: Speculation Trumped Risk at TheStreet
28-Dec-13 02:02PM  Keryx Biopharmaceuticals: The Best Performing Biotechs of 2013 at Motley Fool
02:02PM  Keryx Biopharmaceuticals: The Best Performing Biotechs of 2013
20-Dec-13 07:00AM  Coronado Biosciences Announces Management Changes GlobeNewswire
07:00AM  Coronado Biosciences Announces Management Changes
19-Dec-13 10:40AM  The Future Is Bright: Keryx Biopharmaceuticals Receives Patent Protection at Wall St. Cheat Sheet
10:40AM  The Future Is Bright: Keryx Biopharmaceuticals Receives Patent Protection
09:26AM  The Future Is Bright: Keryx Biopharmaceuticals Receives Patent Protection at Wall St. Cheat Sheet
18-Dec-13 08:30AM  Keryx Biopharmaceuticals Announces Issuance of U.S. Patent for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate GlobeNewswire
08:30AM  Keryx Biopharmaceuticals Announces Issuance of U.S. Patent for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate
15-Dec-13 08:36PM  3 Bold Predictions for Keryx Biopharmaceuticals in 2014 at Motley Fool
08:36PM  3 Bold Predictions for Keryx Biopharmaceuticals in 2014
14-Dec-13 01:08PM  The Single Biggest Development in 2013 for Keryx Biopharmaceuticals at Motley Fool
01:08PM  The Single Biggest Development in 2013 for Keryx Biopharmaceuticals
10-Dec-13 10:28AM  Why You Should Be Bullish On Keryx Biopharmaceuticals at Seeking Alpha
09-Dec-13 08:30AM  Keryx Biopharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference GlobeNewswire
06-Dec-13 06:15PM  Nasdaq stocks posting largest percentage decreases AP
01:33PM  Nasdaq stocks posting largest percentage decreases AP
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. It is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company has completed Phase III clinical program for Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with chronic kidney disease on dialysis. Zerenex has also completed a Phase II study for the management of elevated serum phosphorus levels and iron deficiency anemia in patients with stages three to five non-dialysis dependent chronic kidney disease. The company has sublicense agreements with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. It also has strategic alliances with Panion & BF Biotech, Inc. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oliviero James F IIIChief Financial OfficerApr 03Sale16.462,08734,352302,330Apr 07 07:24 PM
BENTSUR RONChief Executive OfficerApr 03Sale16.461,81629,891878,603Apr 07 07:18 PM
Oliviero James F IIIChief Financial OfficerMar 21Sale15.1113,444203,139304,417Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 20Sale15.04125,0001,880,000317,861Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 19Option Exercise3.54104,039367,812596,900Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerMar 19Sale15.23154,0392,346,014442,861Mar 21 09:30 PM
Oliviero James F IIIChief Financial OfficerJan 03Sale12.576,30979,304492,861Jan 06 08:00 PM
BENTSUR RONChief Executive OfficerJan 03Sale12.575,25766,080880,419Jan 06 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 30Option Exercise4.5930,000137,700506,429Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 30Sale12.6379,5001,003,890476,429Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerDec 27Sale12.6830,000380,400525,929Dec 31 08:00 PM
Oliviero James F IIIChief Financial OfficerOct 03Sale10.251,47515,119555,929Oct 07 07:04 PM
BENTSUR RONChief Executive OfficerOct 03Sale10.252,50525,676459,065Oct 07 07:02 PM
BENTSUR RONChief Executive OfficerJul 05Sale7.952,44019,398461,570Jul 09 07:00 PM
Oliviero James F IIIChief Financial OfficerJul 05Sale7.951,43811,432557,404Jul 09 07:00 PM
Oliviero James F IIIChief Financial OfficerMay 13Sale8.3429,363244,887558,842May 14 07:00 PM